SCHEMBL8154671

SCHEMBL8154671

COc1ccc2c(c1)C(CCO)=C(C)C2=Cc1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
GLA P06280 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
TSHR P16473 1/20 0.53
EDNRA P25101 1/20 0.53
MAPK1 P28482 1/20 0.53
PMP22 Q01453 1/20 0.53
HIF1A Q16665 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
PPARG P37231 2/20 0.42
XDH P47989 2/20 0.42
LCK P06239 2/20 0.42
RXRA P19793 2/20 0.41
PTGS2 P35354 2/20 0.41
HTR6 P50406 1/20 0.41
EGFR P00533 1/20 0.41
AKR1C3 P42330 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8154670 1.00 CYP1A2 (0.53) CYP1A2GLACYP3A4MAPTTSHR
SCHEMBL8142380 0.86 CYP1A2 (0.73) CYP1A2GLACYP3A4MAPTTSHR
SCHEMBL8142377 0.86 CYP1A2 (0.73) CYP1A2GLACYP3A4MAPTTSHR
SCHEMBL2222358 0.86 CYP1A2 (0.73) CYP1A2GLACYP3A4MAPTTSHR
SCHEMBL8142274 0.85 CYP1A2 (0.60) CYP1A2GLACYP3A4MAPTTSHR
SCHEMBL8142277 0.85 CYP1A2 (0.60) CYP1A2GLACYP3A4MAPTTSHR
SCHEMBL8142275 0.85 CYP1A2 (0.60) CYP1A2GLACYP3A4MAPTTSHR
SCHEMBL7927229 0.84 CYP1A2 (0.74) CYP1A2GLACYP3A4MAPTTSHR
SCHEMBL5712302 0.84 CYP1A2 (0.74) CYP1A2GLACYP3A4MAPTTSHR
SCHEMBL5712301 0.84 CYP1A2 (0.74) CYP1A2GLACYP3A4MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6028116-A Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia CELL PATHWAYS, INC. (US) 2000-02-22 US disclosed